XML 106 R90.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments - Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Dec. 31, 2023
Financial Instruments          
Accounts receivable, reserves $ 41,300,000   $ 41,300,000   $ 35,600,000
Investments in equity securities without readily determinable fair values 11,200,000   11,200,000   11,200,000
Cumulative impairment 17,000,000.0   17,000,000.0   17,000,000.0
Impairment loss related to equity securities       $ 5,000,000.0  
Interest expense, net 26,500,000 $ 25,700,000 79,500,000 76,100,000  
Derivative contracts classified within Level 3 of fair value hierarchy 0   0   0
Derivative contracts transfers in to Level 3 fair value hierarchy     0    
Impairment of intangible assets, finite lived       1,900,000  
Property, plant and equipment          
Financial Instruments          
Asset impairment charges     5,500,000 5,400,000  
Right-of-use assets          
Financial Instruments          
Asset impairment charges     900,000 9,600,000  
Interest Rate Swap | Net investment hedge contracts | Designated as Hedging Instrument          
Financial Instruments          
Interest expense, net     1,700,000 $ 1,700,000  
Foreign currency contracts | Designated as Hedging Instrument | Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest          
Financial Instruments          
Pretax gains (losses) related to derivative instruments and hedging activities in accumulated other comprehensive loss $ (82,700,000)   $ (82,700,000)   $ 156,300,000